$MVIS Cashflow Statement | Understand Stock

$MVIS

$1.30 +$0.06 (4.84%) Close

$MVIS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net income
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization
Bargain purchase gain, net of tax
Loss (gain) on disposal of fixed assets
Unrealized (gain) loss on derivative liability
Unrealized gain on warrant liability
Loss on debt extinguishment
Impairment of operating lease right-of-use assets
Impairment of property and equipment
Inventory write-downs
Non-cash interest expense
Amortization of debt discount and issuance costs on notes payable
Share-based compensation expense
Non-cash interest income (expense)
Non-cash interest (income) expense
Non-cash interest income
Net accretion of premium on short-term investments

Change in:
Accounts receivable
Inventory
Other current and non-current assets
Accounts payable
Accrued liabilities
Deferred revenue
Contract liabilities and other current liabilities
Operating lease liabilities
Other long-term liabilities
Net cash used in operating activities

Purchases of investment securities
Sales of investment securities
Purchases of investment securities
Proceeds from Sale of Property, Plant, and Equipment
Advance to Ibeo
Advance to Scantinel
Cash paid for Ibeo business combination
Purchases of property and equipment
Net cash provided by (used in) investing activities
Cash flows from financing activities
Principal payments under finance leases
Proceeds from long-term debt
Payments received on subscriptions receivable
Principal payments under notes payable
Principal proceeds from notes payable, net of debt discount and issuance costs
Proceeds from stock option exercises
Net proceeds from issuance of common stock and warrants
Net cash provided by financing activities

Effect of exchange rate changes on cash and cash equivalents and restricted cash
Change in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of period
Cash, cash equivalents, and restricted cash at end of period
Supplemental schedule of non-cash investing and financing activities
Issuance of common stock for subscriptions receivable
Property and equipment acquired under finance leases
Accrued liability for Ibeo business combination
Common stock issued in conversion of note payable
Non-cash additions to property and equipment
Issuance of warrants
Amounts issued to escrow for acquisition consideration
Acquisition of right-of-use asset
Accrued financing fees
Currency gain in translation
Foreign currency translation adjustments
Unrealized (loss) gain on investment securities, available-for-sale

Comments